Pellef.com

Image Credit: Adobe Stock Images/9DreamStudio.com In 2023, the FDA approved the first over-the-counter (OTC) birth control pill for use in the United States, with Opill becoming available for purchasing in stores and online in April 2024. Oral contraceptive pills (OCP)—those that are progestin-only and combined—are considered effective, and safe, along with simple to use.1 Having […]

In a video interview with Pharma Commerce, Derrick Gastineau, head of marketing with Currax Pharmaceuticals, emphasizes the importance of pricing consistency in improving access, affordability, and long-term adherence to obesity treatments, particularly with FDA-approved oral weight loss drugs. He explained that one of the primary frustrations patients face is the unpredictability of out-of-pocket costs. This […]

In a video interview with Pharma Commerce, Derrick Gastineau, head of marketing with Currax Pharmaceuticals, emphasizes the importance of pricing consistency in improving access, affordability, and long-term adherence to obesity treatments, particularly with FDA-approved oral weight loss drugs. He explained that one of the primary frustrations patients face is the unpredictability of out-of-pocket costs. This […]

Image Credit: Adobe Stock Images/DragoDesigner.com Phononic, a company that specializes cooling technology, including for the pharma sector, has reached a cold chain licensing agreement with Peltier Technology, Inc.1 The company’s branded Active Cooling Solutions (ACS) platform is utilized throughout the cold chain, including in fulfillment centers to last-mile delivery. It also features a combination of […]

Image Credit: Adobe Stock Images/Jordi.com Ascensia Diabetes Care—a part of PHC Group—has signed a memorandum of understanding (MOU) to transfer the commercial operations for its branded Eversense Continuous Glucose Monitoring (CGM) systems to Eversense designer Senseonics Holdings, Inc.1 Pending an official agreement, the parties are aiming to merge Eversense R&D, manufacturing, and commercial services with […]

Ned Milenkovich, PharmD, JD The Most Favored Nation Mandate: What the President’s Drug Pricing Push Means for Pharma, Payers, and Patients Register for the full webinar here! President Trump’s executive order pushing for most-favored-nation (MFN) pricing for pharmaceuticals sent shockwaves through the industry. While most people agree that healthcare and pharmaceuticals are often prohibitively expensive […]

Image Credit: Adobe Stock Images/Wichayada.com According to FirstWord Pharma, Samsung Biologics, a contract development and manufacturing organization (CDMO) based in South Korea, has inked a $1.3 billion production contract with a mega pharma partner in a deal that is expected to run until the end of 2029.1 A corporate filing noted that the company—who is […]

Mark Kunar of DHL Supply Chain North America (left) and Drew Kronick of SDS Rx (right). Image Credit: DHL Supply Chain DHL Supply Chain has officially agreed to purchase SDS Rx, a provider of final-mile delivery and specialized healthcare transportation services for long-term care and specialty pharmacies, radiopharmacies, and health system networks. The closing of […]

In a video interview with Pharma Commerce, Derrick Gastineau, Head of Marketing with Currax Pharmaceuticals, emphasizes the importance of pricing consistency in improving access, affordability, and long-term adherence to obesity treatments, particularly with FDA-approved oral weight loss drugs. He explained that one of the primary frustrations patients face is the unpredictability of out-of-pocket costs. This […]

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re looking at potential new trade restrictions on China-discovered treatments, fresh clinical data on Pfizer and BioNTech’s COVID-19 vaccine, and Samsung Biologics’ US expansion […]

Drug shortages continue to create significant financial and operational strain on hospitals, impacting both patient care and workforce efficiency. In a video interview with Pharma Commerce, Boyede Sobitan, global healthcare strategy lead, and Annika Matas,senior director of product management and business operations, supplies and sensors—both with Zebra Technologies—they describe how hospitals are increasingly forced to adapt […]

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering the latest measles outbreak in Florida, new scrutiny of pharma advertising, and a cost-effectiveness review of obesity treatments. Florida’s Surgeon General has […]

Image Credit: Adobe Stock Images/Enigma Topline Findings Significant Weight Loss Achieved: Zepbound delivers 17.8%–20.8% average weight loss, while injectable Wegovy achieves 14%–17%, and oral Wegovy 11.4%, highlighting effective obesity management options. Cost-Effectiveness Highlighted: All therapies are highly cost-effective at conventional thresholds, with QALY estimates of $53,400 for tirzepatide, $61,400 for injectable semaglutide, and $69,300 for […]

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering a major cardiovascular acquisition by Novartis, new research into flu severity in older adults, and practical solutions for improving medication adherence. Novartis […]

Drug shortages continue to create significant financial and operational strain on hospitals, impacting both patient care and workforce efficiency. In a video interview with Pharma Commerce, Boyede Sobitan, global healthcare strategy lead, and Annika Matas, senior director of product management and business operations, supplies and sensors—both with Zebra Technologies—they describe how hospitals are increasingly forced to […]

Sharmeen Roy, PharmD, BCPS The pharmaceutical industry’s digital shift now influences not just R&D, but delivery, pricing, and utilization. Precision dosing, powered by model-informed tools such as Bayesian analytics and real-time pharmacokinetic modeling, is no longer a clinical “nice-to-have.” It’s a boardroom lever. While the clinical benefits of model-informed precision dosing (MIPD) have been increasingly […]